Overall, the phenotypic differences among the colon cancer cell lines investigated may underlie diverse CRY1 and CRY2 expression patterns and a related genetic landscape that could influence cell survival and response to chemotherapy. This evidence concerns the gene CRY1 and malignant colon neoplasm.